Merging Microplates and Microarrays

Several companies offer arrays printed in microplate wells,1 but Tucson, Ariz.-based High Throughput Genomics Inc. (HTG) is the first to allow processing of small samples in the microplates prior to analysis. The result is "higher sensitivity and reproducibility," says HTG's CEO and president Bruce Seligmann, making the technology ideal for target gene validation or drug dose response profiling. Scientists can use HTG's Multiplexed Molecular Profiling (MMP) technology to assess protein functio

Written byLaura Bonetta
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Scientists can use HTG's Multiplexed Molecular Profiling (MMP) technology to assess protein function and genetic polymorphisms, but the most popular application is measuring the RNA expression levels of a set of genes in multiple samples. Helen Brady, a scientist with San Diego-based Signal Pharmaceuticals, says her company has identified a number of interesting genes through array methods and is now using the HTG's ArrayPlate™ product "to look at the levels of a subset of genes under different conditions."

The technique works by adding linker oligonucleotides to a generic set of 16 "anchors" per well arrayed in a 4 x 4 grid. Each linker binds at one end to the anchor and at the other to a specific target molecule. Tissues or cells to be analyzed are grown, treated, and lysed in one microplate, to which nuclease protection reagents--synthetic sequences of DNA complementary to the RNA targets that protect them from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies